Cogent Biosciences, Inc. Cash Flow Statement

Cash Flow Statement Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -25.77M-34.85M-31.91M-82.06M
Depreciation and Depletion 0.84M2.27M2.45M
Share-based Compensation 1.34M3.09M3.24M6.02M11.69M18.37M30.62M39.74M
Gains from Sales and Divestitures 0.08M
Gains from Investment Securities 3.16M3.66M2.20M7.49M0.10M25.18M0.60M0.10M
Asset Writedowns and Impairment -0.40M
Non-cash Items 2.09M1.80M0.56M
Cash from Operations -25.84M-32.49M-41.51M-35.85M-58.76M-118.64M-153.62M-207.79M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles -0.02M0.25M0.05M1.84M5.04M5.17M7.62M
Amortization of Deferred Charges 0.02M0.02M
Depreciation & Amortization (CF) 1.17M1.32M1.29M0.72M0.15M0.80M2.30M2.50M
Change in Working Capital
Change in Receivables -0.10M0.84M0.33M-2.00M
Change in Account Payables -0.03M0.37M1.66M-2.45M2.75M2.36M4.81M1.36M
Change in Accured Expenses 1.17M2.88M1.76M-2.35M3.43M9.59M8.17M15.96M
Other Working Capital Changes -3.88M-3.84M-16.63M1.47M3.73M-8.69M-0.80M4.33M
Investing Activities
Capital Expenditures 0.91M0.55M0.03M1.72M6.86M2.80M0.57M
Sales of Property, Plant and Equipment 0.20M0.32M
Divestments 8.10M
Change in Acquisitions & Divestments 21.00M37.70M22.99M60.00M253.78M294.45M
Cash from Investing Activities 13.59M-10.53M23.16M8.42M-1.72M-124.72M-97.82M38.28M
Financing Activities
Other financing activities 0.79M2.06M
Cash from Financing Activities -0.73M70.35M0.11M232.20M37.98M163.56M163.54M214.45M
Additional items
Change in Cash -12.98M27.33M-18.25M204.77M-22.51M-79.80M-87.91M44.94M
Free Cash Flow -26.75M-33.04M-41.55M-35.85M-60.48M-125.50M-156.42M-208.36M
Net Cash Flow -12.98M27.33M-18.25M204.77M-22.51M-79.80M-87.91M44.94M